The predictors of survival in Chinese amyotrophic lateral sclerosis patients

References

• Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
   PubMed Web of Science ®Google Scholar
• Jennum P, Ibsen R, Pedersen SW, Kjellberg J. Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study. J Neurol. 2013; 260:785–93.
   PubMed Web of Science ®Google Scholar
• Lee CT, Chiu YW, Wang KC, Hwang CS, Lin KH, Lee IT, et al. Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population based study of 1149 cases in Taiwan. J Epidemiol. 2013; 23:35–40.
   PubMed Web of Science ®Google Scholar
• Chio A, Calvo A, Moglia C, Mazzini L, Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82: 740–6.
   PubMed Web of Science ®Google Scholar
• Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2008;79:33–7.
   PubMed Web of Science ®Google Scholar
• Rooney J, Byrne S, Heverin M, Corr B, Elamin M, Staines A, et al. Survival analysis of Irish amyotrophic lateral sclerosis patients diagnosed from 1995 to2010. PLoS One.2013;8:e74733.
   Google Scholar
• Pupillo E, Messina P, Logroscino G, Beghi E. Long-term survival in amyotrophic lateral sclerosis: a population based study. Ann Neurol. 2014;75:287–97.
   PubMed Web of Science ®Google Scholar
• Turner MR, Parton MJ, Shaw CE, Leigh PN, Al-Chalabi A. Prolonged survival in motor neuron disease: a descriptive study of the King’s database 1990–2002. J Neurol Neurosurg Psychiatry. 2003;74:995–7.
   PubMed Web of Science ®Google Scholar
• Kihira T, Yoshida S, Okamoto K, Kazimoto Y, Ookawa M, Hama K, et al. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005. J Neurol Sci. 2008;268:95–101.
   PubMed Web of Science ®Google Scholar
• del Aguila MA, Longstreth WT, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813–9.
   PubMed Web of Science ®Google Scholar
• Keren N, Scott KM, Tsuda M, Barnwell J, Knibb JA, Ellis CM, et al. Evidence of an environmental effect on survival in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;27:1–6.
   Google Scholar
• Kaufmann P, Levy G, Thompson JLP, DelBene ML, Battista V, Gordon PH, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology. 2005;64:38–43.
   PubMed Web of Science ®Google Scholar
• Kollewe K, Mauss U, Krampfl K, Petri S, Dengler R, Mohammadi B. ALSFRS-R score and its ratio: a useful predictor for ALS progression. J Neurol Sci. 2008;275:69–73.
   PubMed Web of Science ®Google Scholar
• Chio A, Calvo A, Ghiglione P, Mazzini L, Mutani R, Mora G, et al. Tracheostomy in amyotrophic lateral sclerosis: a 10-year population based study in Italy. J Neurol Neurosurg Psychiatry. 2010;81:1141–3.
   PubMed Web of Science ®Google Scholar
• Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis. Lancet Neurol. 2006;5:140–7.
   PubMed Web of Science ®Google Scholar
• Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76:1263–9.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Goetz RR, Rabkin JG, Dalton K, McElhiney M, Hays AP, et al. A prospective cohort study of neuropsychological test performance in ALS. Amyotroph Lateral Scler. 2010;11:312–20.
   PubMed Web of Science ®Google Scholar
• Nelson LM, McGuire V, Longstreth WT Jr, Matkin C. Population based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. Am J Epidemiol. 2000;151: 156–63.
   PubMed Web of Science ®Google Scholar
• Vinceti M, Fiore M, Signorelli C, Odone A, Tesauro M, Consonni M, et al. Environmental risk factors for amyotrophic lateral sclerosis: methodological issues in epidemiologic studies. Ann Ig. 2012;24:407–15.
   PubMedGoogle Scholar
• Boumediene F, Druet-Cabanac M, Marin B, Preux PM, Allee P, Couratier P. Contribution of geolocalization to neuroepidemiological studies: incidence of ALS and environmental factors in Limousin, France. J Neurol Sci. 2011;309:115–22.
   PubMed Web of Science ®Google Scholar
• Mitchell JD. Amyotrophic lateral sclerosis: toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:235–50.
   PubMed Web of Science ®Google Scholar
• Syriani E, Morales M, Gamez J. The p.E22G mutation in the Cu/Zn superoxide-dismutase gene predicts a long survival time: clinical and genetic characterization of a seven-generation ALS1 Spanish pedigree. J Neurol Sci. 2009;285:46–53.
   PubMed Web of Science ®Google Scholar
• Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol. 1997;41:210–21.
   PubMed Web of Science ®Google Scholar
• Chio A, Mora G, Restagno G, Brunetti M, Ossola I, Barberis M, et al. UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population based study. Neurobiol Aging. 2013;34:357, e1–5.
   Web of Science ®Google Scholar
• Irwin DJ, McMillan CT, Brettschneider J, Libon DJ, Powers J, Rascovsky K, et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84:163–9.
   PubMed Web of Science ®Google Scholar
• Zou ZY, Li XG, Liu MS, Cui LY. Screening for C9orf72 repeat expansions in Chinese amyotrophic lateral sclerosis patients. Neurobiol Aging. 2013;34:1710, e5–6.
   Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Yang R, Huang R, Chen D, Song W, Zeng Y, Zhao B, et al. Causes and places of death of patients with amyotrophic lateral sclerosis in south-west China. Amyotroph Lateral Scler. 2011;12:206–9.
   PubMed Web of Science ®Google Scholar
• Cui F, Liu M, Chen Y, Huang X, Cui L, Fan D, et al. Epidemiological characteristics of motor neuron disease in Chinese patients. Acta Neurol Scand. 2014;130:111–7.
   PubMed Web of Science ®Google Scholar
• Atsuta N, Watanabe H, Ito M, Tanaka F, Tamakoshi A, Nakano I, et al. Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J Neurol Sci. 2009;276:163–9.
   PubMed Web of Science ®Google Scholar
• Nalini A, Thennarasu K, Gourie-Devi M, Shenoy S, Kulshreshtha D. Clinical characteristics and survival pattern of 1153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. J Neurol Sci. 2008; 272:60–70.
   PubMed Web of Science ®Google Scholar
• Martinez HR, Francisco Molina-Lopez J, Cantu-Martinez L, Teresa Gonzalez-Garza M, Moreno-Cuevas JE, Couret-Alcaraz P, et al. Survival and clinical features in Hispanic amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler. 2011;12:199–205.
   PubMed Web of Science ®Google Scholar
• Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve. 1993;16:27–32.
   PubMed Web of Science ®Google Scholar
• Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J Neurol Neurosurg Psychiatry. 2003;74: 1258–61.
   PubMed Web of Science ®Google Scholar
• Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. Riluzole and amyotrophic lateral sclerosis survival: a population based study in southern Italy. Eur J Neurol. 2007;14:262–8.
   PubMed Web of Science ®Google Scholar
• Heiman-Patterson TD, Miller RG. NIPPV: a treatment for ALS whose time has come. Neurology. 2006;67:736–7.
   PubMed Web of Science ®Google Scholar
• Spataro R, Ficano L, Piccoli F, La Bella V. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival. J Neurol Sci. 2011;304:44–8.
   PubMed Web of Science ®Google Scholar
• Pena MJ, Ravasco P, Machado M, Pinto A, Pinto S, Rocha L, et al. What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2012;13:550–4.
   PubMed Web of Science ®Google Scholar
• Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology. 2002;59:99–103.
   PubMed Web of Science ®Google Scholar
• Forbes RB, Colville S, Swingler RJ. Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neuron disease – a record linkage study from the Scottish Motor Neurone Disease Register. J Neurol. 2004;251:813–7.
   PubMed Web of Science ®Google Scholar
• Heffernan C, Jenkinson C, Holmes T, Feder G, Kupfer R, Leigh PN, et al. Nutritional management in MND/ALS patients: an evidence based review. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5: 72–83.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.
   PubMed Web of Science ®Google Scholar
• Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G, Grp S. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141–5.
   PubMed Web of Science ®Google Scholar